• Latest Posts
Weekly Roundup 24 Nov 2023

Viva’s $210 million round; Merck grabs Caraway for $610 million; Genentech signs a deal with NVIDIA 

M&As: what’s up with the ADC buying spree?

Weekly Roundup 10 Nov 2023

Korro Bio and Frequency’s merger; Lexeo’s $100 million IPO; Gate Biosciences new class of drugs

In Depth 27 Oct 2023

Big pharma monopolies: major antitrust cases over the past decade

Biogen acquiring Reata Pharmaceuticals for $7.3B

ADVERTISEMENT

Sosei Heptares hails ‘transformational’ acquisition

Korro Bio and Frequency Therapeutics to merge

Boost for Charcot-Marie-Tooth patients as Novartis acquires DTx Pharma

Lilly boosts obesity portfolio with Versanis Bio acquisition

In Depth 22 Jun 2023

Brace yourself for a wave of biotech layoffs

Novartis acquires Chinook Therapeutics for $3.2B

ADVERTISEMENT